305
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Dapagliflozin Improves Erythropoiesis and Iron Metabolism in Type 2 Diabetic Patients with Renal Anemia

, , , , , , & ORCID Icon show all
Pages 1799-1808 | Received 20 Mar 2023, Accepted 08 Jun 2023, Published online: 20 Jun 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.